MIR4429 Gene

HGNC Family Non-coding RNAs
Name microRNA 4429
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐4429 (miR‐4429) has emerged as a critical tumor‐suppressive regulator in several cancers via directly targeting key oncogenic mediators. In gastric cancer, for instance, miR‐4429 targets METTL3 to inhibit m⁶A‐mediated stabilization of SEC62 and thereby suppress proliferation while promoting apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In cervical cancer, miR‐4429 enhances radiosensitivity by binding to RAD51 and impairing DNA repair, thus reducing radio‐resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, in papillary thyroid carcinoma, downregulation of miR‐4429—resulting from sponging by the oncogenic lncRNA LINC00313—leads to tumor progression that can be reversed upon restoration of miR‐4429 levels."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In clear cell renal cell carcinoma, miR‐4429 functions to inhibit tumor cell proliferation, migration, invasion, and epithelial–mesenchymal transition by directly targeting CDK6."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In glioblastoma, an oncogenic feedback loop is established whereby the lncRNA DLEU1 sequesters miR‐4429 to result in SP1 overexpression, while re‐establishing miR‐4429 levels attenuates these deleterious effects."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these contexts, miR‐4429 is implicated in modulating tumor progression in a range of other malignancies. In ovarian cancer, its altered expression has been linked to changes in cell migratory potential"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", and in prostate cancer miR‐4429 regulates oncogenic pathways to restrain disease advancement."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In esophageal squamous cell carcinoma, the circular RNA circABCA13 functions as a molecular sponge for miR‐4429, which leads to increased SRXN1 expression and promotes malignancy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In non‐small cell lung cancer, miR‐4429 directly binds to EGFR, with lower miR‐4429 levels correlating with increased EGFR expression and poorer prognosis; this observation is further underscored by studies involving the LINC00313/miR‐4429 axis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " In colon cancer, miR‐4429‐5p suppresses tumor cell proliferation, migration, and invasion by directly targeting MMP16."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " In renal cell carcinoma, overexpression of the lncRNA FTX sponges miR‐4429 to release UBE2C from inhibition, thereby promoting cell cycle progression and tumor aggressiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": " Moreover, in gastric cancer, exosomal circKIAA1797 sequesters miR‐4429 to modulate PBX3 expression, leading to enhanced malignant phenotypes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNotably, miR‐4429 is also of interest beyond oncology; dysregulated levels in the blood of schizophrenia patients highlight its potential as a novel biomarker for early diagnosis and prognosis in neuropsychiatric disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Huabo He, Wei Wu, Zhener Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A-caused stabilization of SEC62."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2019.07.058"}], "href": "https://doi.org/10.1016/j.bbrc.2019.07.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31395342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31395342"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hongbo Sun, Guimei Fan, Chunxia Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.28957"}], "href": "https://doi.org/10.1002/jcp.28957"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31190335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31190335"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "W J Wu, H Yin, J J Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2018_180219N125"}], "href": "https://doi.org/10.4149/neo_2018_180219N125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29940766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29940766"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hong Pan, Yejing Hong, Biying Yu, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "miR-4429"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via Targeting "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "CDK6"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " in Clear Cell Renal Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biother Radiopharm (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cbr.2018.2697"}], "href": "https://doi.org/10.1089/cbr.2018.2697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30844301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30844301"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaolei Liu, Ruwei Chen, Lijun Liu "}, {"type": "b", "children": [{"type": "t", "text": "SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20190994"}], "href": "https://doi.org/10.1042/BSR20190994"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31713587"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31713587"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Y-M Zhu, P Chen, L Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-4429 suppresses the malignant development of ovarian cancer by targeting YOD1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202009_22809"}], "href": "https://doi.org/10.26355/eurrev_202009_22809"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32964960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32964960"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jinguo Wang, Sheng Xie, Jun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-4429 suppresses proliferation of prostate cancer cells by targeting distal-less homeobox 1 and inactivating the Wnt/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Urol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12894-021-00810-x"}], "href": "https://doi.org/10.1186/s12894-021-00810-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33740948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33740948"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Junwen Luo, Zhongxian Tian, Yongjia Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircABCA13 acts as a miR-4429 sponge to facilitate esophageal squamous cell carcinoma development by stabilizing SRXN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.15807"}], "href": "https://doi.org/10.1111/cas.15807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37017121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37017121"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Mei Ruan, Liyan Sun, Wen Qiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bosn J Basic Med Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.17305/bjbms.2021.6450"}], "href": "https://doi.org/10.17305/bjbms.2021.6450"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35167433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35167433"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jinxiang Wang, Lihua Zhang, Caihong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00313/miR-4429 axis provides novel biomarkers for the diagnosis and prognosis of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Pol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18388/abp.2020_5794"}], "href": "https://doi.org/10.18388/abp.2020_5794"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35485050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35485050"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Wei Li, Zhe Song, Nan Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-4429-5p suppresses the malignant development of colon cancer by targeting matrix metalloproteinase 16."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vitro Cell Dev Biol Anim (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11626-021-00603-4"}], "href": "https://doi.org/10.1007/s11626-021-00603-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34448115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34448115"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zhiping Chen, Mengting Zhang, Yukang Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2022.8378"}], "href": "https://doi.org/10.3892/or.2022.8378"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35866591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35866591"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xiaomei Zheng, Hongwei Xiao, Xiaoxiao Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal circKIAA1797 Regulates Cell Progression and Glycolysis by Targeting miR-4429/PBX3 Pathway in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-023-10529-z"}], "href": "https://doi.org/10.1007/s10528-023-10529-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37730964"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37730964"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Omran Davarinejad, Sajad Najafi, Hossein Zhaleh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Neurosci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12031-021-01945-0"}], "href": "https://doi.org/10.1007/s12031-021-01945-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34811713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34811713"}]}]}]}
Synonyms MIR-4429
NCBI Gene ID 100616469
API
Download Associations
Predicted Functions View MIR4429's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR4429's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR4429's ARCHS4 Predicted Functions.

Functional Associations

MIR4429 has 465 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.

Click the + buttons to view associations for MIR4429 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4429 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4429 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4429 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR4429 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR4429 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR4429 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR4429 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR4429 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.